To determine whether endothelial glycocalyx could be protected or restored in DKD, a pharmacological approach was adopted, and MMPI, a highly selective inhibitor for MMP2 and -970 was given therapeutically after the onset of albuminuria. The gene discussed is MMP2; the disease is diabetic kidney disease.